Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man.
Saved in:
| Title: | Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man. |
|---|---|
| Authors: | Lopera F; Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medellín, Colombia.; Medicine School, University of Antioquia, Medellín, Colombia., Marino C; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Chandrahas AS; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., O'Hare M; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Villalba-Moreno ND; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Aguillon D; Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medellín, Colombia.; Medicine School, University of Antioquia, Medellín, Colombia., Baena A; Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medellín, Colombia., Sanchez JS; Department of Neurology at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Vila-Castelar C; Department of Psychiatry at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Ramirez Gomez L; Department of Neurology at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Chmielewska N; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Oliveira GM; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.; Department of Psychiatry at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Littau JL; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hartmann K; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Park K; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Krasemann S; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Glatzel M; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schoemaker D; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.; Department of Psychiatry at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Gonzalez-Buendia L; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Delgado-Tirado S; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Arevalo-Alquichire S; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Saez-Torres KL; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Amarnani D; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Kim LA; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Mazzarino RC; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Gordon H; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA., Bocanegra Y; Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medellín, Colombia., Villegas A; Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medellín, Colombia.; Medicine School, University of Antioquia, Medellín, Colombia., Gai X; Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.; Department of Pathology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA., Bootwalla M; Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA., Ji J; Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.; Department of Pathology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA., Shen L; Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA., Kosik KS; Neuroscience Research Institute, Department of Molecular Cellular Developmental Biology, University of California, Santa Barbara, CA, USA., Su Y; The Banner Alzheimer's Institute, Phoenix, AZ, USA., Chen Y; The Banner Alzheimer's Institute, Phoenix, AZ, USA., Schultz A; Department of Neurology at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Sperling RA; Department of Neurology at Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA., Johnson K; Department of Neurology at Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.; Department of Radiology at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA., Reiman EM; The Banner Alzheimer's Institute, Phoenix, AZ, USA.; University of Arizona, Tucson, AZ, USA.; Arizona State University, Tucson, AZ, USA.; Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Sepulveda-Falla D; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. d.sepulveda-falla@uke.uni-hamburg.de., Arboleda-Velasquez JF; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA. joseph_arboleda@meei.harvard.edu., Quiroz YT; Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medellín, Colombia. yquiroz@mgh.harvard.edu.; Department of Neurology at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. yquiroz@mgh.harvard.edu.; Department of Psychiatry at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. yquiroz@mgh.harvard.edu. |
| Source: | Nature medicine [Nat Med] 2023 May; Vol. 29 (5), pp. 1243-1252. Date of Electronic Publication: 2023 May 15. |
| Publication Type: | Case Reports; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
